GS-011

N/A

Report date: 2023/10/26 16:49:36

Base Information

Drug NameGS-011
Drug Alias NameGS-011
ClassificationCell and gene therapy > Gene therapy > Viral vector-based gene therapy > Adeno-associated virus vector
Mechanisms of ActionGene transferenceMitochondrial complex I (NADH dehydrogenase) inhibitors
TargetsMitochondrial complex I (NADH dehydrogenase)
Therapy Area/IndicationsOptic Atrophy, Hereditary, Leber
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesGensight Biologics
China Registration ClassN/A

Develop Information

Active CompaniesGensight Biologics
Inactive CompaniesN/A
Active IndicationsOptic Atrophy, Hereditary, Leber
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A